Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRELID1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | RP11-864I4.1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | CCDC142 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | AP000275.65 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | FAM9A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | GAGE1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | SNAPC5 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | PLXNC1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | VWCE | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | MBTD1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |